欧洲药品的卫生技术评估：会雷声大雨点小吗？ - Suppr

Suppr

超能文献

HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

作者信息

Garattini Livio, Padula Anna

机构信息

CESAV, Centre for Health Economics, Institute for Pharmacological Research Mario Negri IRCCS, 24020, Ranica, Italy.

出版信息

Eur J Health Econ. 2020 Feb;21(1):1-5. doi: 10.1007/s10198-019-01103-9.

DOI:10.1007/s10198-019-01103-9

PMID:31440857

Abstract

摘要

相似文献

HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Eur J Health Econ. 2020 Feb;21(1):1-5. doi: 10.1007/s10198-019-01103-9.

The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.

Pharmacoeconomics. 2017 Dec;35(12):1287-1296. doi: 10.1007/s40273-017-0562-9.

Economic evaluation approaches for new technology.

IEEE Eng Med Biol Mag. 2003 May-Jun;22(3):16-7. doi: 10.1109/memb.2003.1213621.

Health technology assessment for medical devices in Europe. What must be considered.

Int J Technol Assess Health Care. 2002 Summer;18(3):733-40.

Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes?

Pharmacoeconomics. 2019 May;37(5):627-630. doi: 10.1007/s40273-019-00781-w.

Evidence-based decision-making 3: Health technology assessment.

Methods Mol Biol. 2015;1281:417-41. doi: 10.1007/978-1-4939-2428-8_25.

An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?

Eur J Health Econ. 2019 Apr;20(3):329-332. doi: 10.1007/s10198-019-01037-2.

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.

Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27.

Most important barriers and facilitators of HTA usage in decision-making in Europe.

Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):297-304. doi: 10.1080/14737167.2018.1421459. Epub 2018 Jan 5.

Assessing new health technologies: lessons to be learned from drugs.

Med J Aust. 1999 Nov 15;171(10):554-6. doi: 10.5694/j.1326-5377.1999.tb123795.x.

引用本文的文献

Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'.

Pharmacoeconomics. 2020 Jan;38(1):121-122. doi: 10.1007/s40273-019-00875-5.

本文引用的文献

PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT.

Int J Technol Assess Health Care. 2018 Jan;34(2):131-133. doi: 10.1017/S0266462318000107. Epub 2018 Apr 3.

Most important barriers and facilitators of HTA usage in decision-making in Europe.

Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):297-304. doi: 10.1080/14737167.2018.1421459. Epub 2018 Jan 5.

The Role of Noncomparative Evidence in Health Technology Assessment Decisions.

Value Health. 2017 Dec;20(10):1245-1251. doi: 10.1016/j.jval.2017.06.015. Epub 2017 Sep 12.

THE ADDED VALUE OF INTEGRATE-HTA GUIDANCE IN THE WORK PROCESSES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES.

Int J Technol Assess Health Care. 2017 Jan;33(5):597-598. doi: 10.1017/S0266462317001027. Epub 2017 Nov 8.

INTEGRATE-HTA: THE PERSPECTIVE OF EUnetHTA.

Int J Technol Assess Health Care. 2017 Jan;33(5):605-608. doi: 10.1017/S0266462317000691. Epub 2017 Sep 6.

Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?

Appl Health Econ Health Policy. 2018 Feb;16(1):1-4. doi: 10.1007/s40258-017-0345-7.

A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?

Front Pharmacol. 2017 Jun 30;8:384. doi: 10.3389/fphar.2017.00384. eCollection 2017.

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.

Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27.

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.

Eur J Health Econ. 2018 Jan;19(1):123-152. doi: 10.1007/s10198-017-0871-0. Epub 2017 Mar 16.

Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?

J R Soc Med. 2017 Mar;110(3):98-103. doi: 10.1177/0141076817690395. Epub 2017 Jan 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验